Track Acutaas Chemicals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -3.17 %
Low
3,346.2
High
3,740.0
1 Month returns: 4.31 %
Low
2,960.0
High
3,740.0
1 Year returns: 213.67 %
Low
1,095.4
High
3,740.0
3 Year CAGR: 75.51 %
Low
502.2
High
3,740.0
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Acutaas Chemicals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Acutaas Chemicals Ltd. Shareholding Pattern
Quarterly breakdown of Acutaas Chemicals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Acutaas Chemicals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Acutaas Chemicals Ltd.?
The current share price of Acutaas Chemicals Ltd. is ₹ 3,454.50 as of 8 Jul 2026.
What is the market capitalisation of Acutaas Chemicals Ltd.?
The market capitalisation of Acutaas Chemicals Ltd. stands at ₹ 28,282.30 Cr.
What is the PE ratio of Acutaas Chemicals Ltd.?
The Price-to-Earnings (PE) ratio of Acutaas Chemicals Ltd. is 79.39 as of the latest trailing twelve months data.
What is the ROE and ROCE of Acutaas Chemicals Ltd.?
Acutaas Chemicals Ltd. has a Return on Equity (ROE) of 24.05% and a Return on Capital Employed (ROCE) of 28.86% as per the latest financial reports.
What is the 52-week high and low of Acutaas Chemicals Ltd.?
The 52-week high of Acutaas Chemicals Ltd. is - and the 52-week low is -.
What is the dividend yield of Acutaas Chemicals Ltd.?
The dividend yield of Acutaas Chemicals Ltd. is 0.04% based on the current market price.
What is the FII and DII holding in Acutaas Chemicals Ltd.?
Foreign Institutional Investors (FII) hold 19.48%, Domestic Institutional Investors (DII) hold 17.11% and retail/public investors hold 26.74% of Acutaas Chemicals Ltd. shares.
What sector does Acutaas Chemicals Ltd. belong to?
Acutaas Chemicals Ltd. operates in the Healthcare sector. 88.89% of analysts have a Buy or Strong Buy rating on Acutaas Chemicals Ltd. with a consensus target price of ₹ 2,900.00, implying 16.05% downside from current levels.
What is the beta of Acutaas Chemicals Ltd.?
The beta of Acutaas Chemicals Ltd. is 0.93, indicating its price volatility relative to the broader market. Over the past 1 year, Acutaas Chemicals Ltd. has delivered an absolute return of 201.86%.
What is the RSI of Acutaas Chemicals Ltd.?
The 14-day Relative Strength Index (RSI) of Acutaas Chemicals Ltd. is 58.25, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Acutaas Chemicals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong price momentum
Price Momentum score of 99.1 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term
What is Price Momentum score?
99.1 / 100
Analysts have been raising forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has increased by 13.11% in the last 3 months, indicating earnings momentum
What is Earnings upgrade (3M)?
High and improving ROE
The company reported strong ROE of 24.05% for 12-month ended 31 Mar 2026 and ROE improved by 805 bps from 1 year ago
What is ROE (FY)?
High and improving operating margin
The company reported strong operating margin of 33.18% for 12-month ended 31 Mar 2026 and operating margin improved by 1277 bps from 1 year ago
What is Operating profit margin?
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 33.02% for 12-month ended 31 Mar 2026 and the growth was 21.78 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 11.24
Value 33.02
-82.35114662
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 118.95% for 12-month ended 31 Mar 2026 and the growth was 110.83 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.02 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 4 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 79.39 indicates that the stock is expensive on a standalone basis and is at a 161.41% premium to industry median P/E
What is P/E Ratio?
Median: 30.37
Value 79.39
-215.443255.34
Low dividend yield
The company has a low dividend yield of 0.04%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 54.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
54.1 / 100
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I (13)).
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Mar 2013
Sep 2014
Sep 2015
Aug 2016
May 2018
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Promoter
0.00
0.00
100.00
98.33
81.00
41.05
41.05
41.05
41.05
39.41
39.41
39.41
39.41
38.93
39.91
39.91
35.98
35.97
35.96
35.96
32.66
32.66
32.66
32.66
Indian Promoter
0.00
0.00
100.00
98.33
81.00
41.05
41.05
41.05
41.05
39.41
39.41
39.41
39.41
38.93
39.91
39.91
35.98
35.97
35.96
35.96
32.66
32.66
32.66
32.66
Foreign Promoter
0.00
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.00
0.00
0.00
0.00
0.00
13.13
5.15
7.86
6.04
9.37
10.13
9.99
11.85
13.10
19.23
15.78
27.73
33.80
35.77
34.80
39.33
39.45
38.38
39.09
Mutual Funds / UTI
0.00
0.00
0.00
0.00
0.00
3.26
1.36
1.77
2.08
2.75
3.31
3.41
4.49
4.44
5.44
3.92
8.61
13.07
13.68
13.02
16.27
15.81
15.11
13.86
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
4.04
1.27
2.67
0.93
0.53
0.09
0.07
0.00
0.00
0.11
0.31
3.22
4.21
4.00
2.97
4.68
4.84
4.15
3.25
Govt
0.00
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
0.01
0.01
0.01
0.01
0.01
0.01
FII
0.00
0.00
0.00
0.00
0.00
3.64
1.34
2.23
1.84
5.76
6.41
6.36
6.73
7.15
11.66
8.98
12.93
13.87
15.52
16.48
16.94
16.84
16.67
19.48
Other Institutions
0.00
0.00
0.00
0.00
0.00
2.19
1.18
1.18
1.18
0.33
0.33
0.15
0.63
1.51
2.03
2.57
2.98
2.65
2.55
2.32
1.43
1.94
2.44
2.49
Non-Institution
100.00
100.00
0.00
1.67
19.00
45.81
53.80
51.08
52.91
51.22
50.46
50.60
48.74
47.97
40.86
44.31
36.29
30.23
28.27
29.23
28.01
27.89
28.96
28.24
Bodies Corporate
0.00
0.00
0.00
0.00
0.00
2.21
1.53
1.37
4.88
8.21
8.98
8.71
8.93
8.91
10.42
10.49
6.78
1.99
1.58
1.74
1.62
1.61
1.63
1.50
Others (incl. Retail)
No. of shareholders
100.00
8
100.00
8
0.00
0
1.67
2
19.00
0
43.60
1,38,039
52.27
97,354
49.71
93,720
48.03
86,834
43.01
85,328
41.48
80,316
41.89
78,569
39.81
70,042
39.06
72,583
30.44
82,921
33.82
95,269
29.51
90,411
28.24
92,762
26.69
95,089
27.49
1,13,236
26.39
1,19,120
26.28
1,07,823
27.33
1,09,480
26.74
1,11,892
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
Vijay Gosar
Designated Person
March-2026
Market Sale (Disposal)
10th Mar 2026
0.00 %
₹ 2,144.26
500.00
₹ 10.72 lac
MEHUL MANSUKHBHAI KOLADIA
Designated Person
February-2026
Market Sale (Disposal)
20th Feb 2026
0.43 %
₹ 2,110.21
20.00 k
₹ 4.22 cr
Bhavesh Mansukhbhai Kotadiya
Designated Person
December-2025
Market Purchase (Acquisition)
30th Dec 2025
0.00 %
₹ 1,672.34
2.10 k
₹ 35.12 lac
CHETANKUMAR CHHAGANLAL VAGHASIA
Promoter & Director
May-2025
Block Deal (Disposal)
20th May 2025
16.62 %
₹ 1,115.00
13.49 lac
₹ 150.41 cr
NARESHKUMAR RAMJIBHAI PATEL
Promoter & Director
May-2025
Block Deal (Disposal)
20th May 2025
19.34 %
₹ 1,115.00
13.49 lac
₹ 150.41 cr
RAM MOHAN LOKHANDE
Director
January-2025
Market Sale (Disposal)
6th Jan 2025
0.00 %
₹ 2,130.00
400.00
₹ 8.52 lac
MEHUL MANSUKHBHAI KOLADIA
Employee
September-2024
Market Sale (Disposal)
17th Sep 2024
0.49 %
₹ 1,540.41
25.00 k
₹ 3.85 cr
CHETANKUMAR CHHAGANLAL VAGHASIA
Promoter
December-2023
Market Purchase (Acquisition)
28th Dec 2023
8.40 %
₹ 1,163.26
86.00 k
₹ 10.00 cr
NARESHKUMAR RAMJIBHAI PATEL
Promoter
December-2023
Off Market (Acquisition)
28th Dec 2023
10.86 %
₹ 1,164.00
2.75 lac
₹ 32.00 cr
Parulben Vaghasia
Promoter
September-2022
Block Deal (Disposal)
14th Sep 2022
8.89 %
₹ 1,037.25
3.00 lac
₹ 31.12 cr
Corporate Actions
History of Acutaas Chemicals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 1.50/share
Record date: 18th Sep 2025Ex-date: 18th Sep 2025
Announced on: 2nd May 2025
Stock Split1 : 2
Ex-date: 25th Apr 2025Announced on: 21st Feb 2025
Nominal value change from INR 10 to INR 5.
Dividend₹ 3/share
Record date: 13th Sep 2024Ex-date: 13th Sep 2024
Announced on: 10th May 2024
Dividend₹ 3/share
Record date: 18th Sep 2023Ex-date: 18th Sep 2023
Announced on: 15th May 2023
Dividend₹ 3/share
Record date: 1st Aug 2022Ex-date: 29th Jul 2022
Announced on: 16th May 2022
Company Profile
Overview of Acutaas Chemicals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 610 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas.
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical...
Key personnel
Mr. Bhavin N. Shah
Chief Financial Officer
Mr. Chetansinh Parmar
Chief Information Security Officer
Mrs. Ekta Kumari Srivastava
Company Secretary and Compliance Officer
Mr. Nareshkumar Ramjibhai PatelD
Executive Chairman of the Board and Managing Director